Recently, the association between the IGF-I and IGFBP-3 polymorphisms and the risk of various cancers, including PCa, has been clarified by many genetic approaches using single amino acid mutations and by molecular epidemiological studies [17], [18], [28], [29], [30], [31]. This evidence concerns the gene IGFBP3 and cancer.